It is projected that the North American market for treatments for irritable bowel syndrome (IBS) would produce around US$ 1,722 million in sales by 2024. The North American market is being driven by customized IBS treatment solutions since patient-centric care models are becoming more and more popular in the US and Canada.  The market for treatments for irritable bowel syndrome is...